| EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies N Aide, C Lasnon, P Veit-Haibach, T Sera, B Sattler, R Boellaard European journal of nuclear medicine and molecular imaging 44, 17-31, 2017 | 244 | 2017 |
| Efficiency of [18F]FDG PET in characterising renal cancer and detecting distant metastases: a comparison with CT N Aide, O Cappele, P Bottet, H Bensadoun, A Regeasse, F Comoz, ... European journal of nuclear medicine and molecular imaging 30, 1236-1245, 2003 | 235 | 2003 |
| FDG PET/CT for assessing tumour response to immunotherapy: Report on the EANM symposium on immune modulation and recent review of the literature N Aide, RJ Hicks, C Le Tourneau, S Lheureux, S Fanti, E Lopci European journal of nuclear medicine and molecular imaging 46, 238-250, 2019 | 188 | 2019 |
| Can fluorodihydroxyphenylalanine PET replace somatostatin receptor scintigraphy in patients with digestive endocrine tumors? F Montravers, D Grahek, K Kerrou, P Ruszniewski, V de Beco, N Aide, ... Journal of Nuclear Medicine 47 (9), 1455-1462, 2006 | 148 | 2006 |
| Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients C Lasnon, C Desmonts, E Quak, R Gervais, P Do, C Dubos-Arvis, N Aide European journal of nuclear medicine and molecular imaging 40, 985-996, 2013 | 128 | 2013 |
| Clinical Relevance of Single-Photon Emission Computed Tomography/Computed Tomography of the Neck and Thorax in Postablation 131I Scintigraphy for … N Aide, N Heutte, JP Rame, E Rousseau, C Loiseau, M Henry-Amar, ... The Journal of Clinical Endocrinology & Metabolism 94 (6), 2075-2084, 2009 | 128 | 2009 |
| Dual-phase 99mTc sestamibi scintigraphy with neck and thorax SPECT/CT in primary hyperparathyroidism: a single-institution experience R Ciappuccini, J Morera, P Pascal, JP Rame, N Heutte, N Aide, E Babin, ... Clinical nuclear medicine 37 (3), 223-228, 2012 | 108 | 2012 |
| Dual-phase 99mTc sestamibi scintigraphy with neck and thorax SPECT/CT in primary hyperparathyroidism: a single-institution experience R Ciappuccini, J Morera, P Pascal, JP Rame, N Heutte, N Aide, E Babin, ... Clinical nuclear medicine 37 (3), 223-228, 2012 | 108 | 2012 |
| F18-choline PET/CT guided surgery in primary hyperparathyroidism when ultrasound and MIBI SPECT/CT are negative or inconclusive: the APACH1 study E Quak, D Blanchard, B Houdu, Y Le Roux, R Ciappuccini, B Lireux, ... European Journal of Nuclear Medicine and Molecular Imaging 45, 658-666, 2018 | 107 | 2018 |
| Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients E Quak, PY Le Roux, MS Hofman, P Robin, D Bourhis, J Callahan, ... European journal of nuclear medicine and molecular imaging 42, 2072-2082, 2015 | 104 | 2015 |
| Postablation 131I scintigraphy with neck and thorax SPECT–CT and stimulated serum thyroglobulin level predict the outcome of patients with differentiated thyroid … R Ciappuccini, N Heutte, G Trzepla, JP Rame, D Vaur, N Aide, S Bardet European journal of endocrinology 164 (6), 961-969, 2011 | 87 | 2011 |
| [18F]FDG in recurrent breast cancer: diagnostic performances, clinical impact and relevance of induced changes in management D Grahek, F Montravers, K Kerrou, N Aide, JP Lotz, JN Talbot European Journal of Nuclear Medicine and Molecular Imaging 31, 179-188, 2004 | 75 | 2004 |
| Phase II study of a radiotherapy total dose increase in hypoxic lesions identified by 18F-misonidazole PET/CT in patients with non–small cell lung carcinoma (RTEP5 study) P Vera, S Thureau, P Chaumet-Riffaud, R Modzelewski, P Bohn, ... Journal of Nuclear Medicine 58 (7), 1045-1053, 2017 | 74 | 2017 |
| High-contrast PET of melanoma using 18F-MEL050, a selective probe for melanin with predominantly renal clearance D Denoyer, I Greguric, P Roselt, OC Neels, N Aide, SR Taylor, A Katsifis, ... Journal of Nuclear Medicine 51 (3), 441-447, 2010 | 73 | 2010 |
| F18-choline, a novel PET tracer for parathyroid adenoma? E Quak, S Lheureux, Y Reznik, S Bardet, N Aide The Journal of Clinical Endocrinology & Metabolism 98 (8), 3111-3112, 2013 | 69 | 2013 |
| Baseline 18F-FDG PET radiomic features as predictors of 2-year event-free survival in diffuse large B cell lymphomas treated with immunochemotherapy N Aide, C Fruchart, C Nganoa, AC Gac, C Lasnon European radiology 30, 4623-4632, 2020 | 64 | 2020 |
| Impact of point spread function reconstruction on thoracic lymph node staging with 18F-FDG PET/CT in non–small cell lung cancer C Lasnon, RJ Hicks, JM Beauregard, A Milner, M Paciencia, AV Guizard, ... Clinical nuclear medicine 37 (10), 971-976, 2012 | 64 | 2012 |
| Giant-cell arteritis: concordance study between aortic CT angiography and FDG-PET/CT in detection of large-vessel involvement H De Boysson, A Dumont, E Liozon, M Lambert, J Boutemy, G Maigné, ... European journal of nuclear medicine and molecular imaging 44, 2274-2279, 2017 | 62 | 2017 |
| Impact of [18F]-fluorodeoxyglucose ([18F]-FDG) imaging in sarcoidosis: unsuspected neurosarcoidosis discovered by [18F]-FDG PET and early metabolic … N Aide, M Benayoun, K Kerrou, A Khalil, J Cadranel, JN Talbot The British journal of radiology 80 (951), e67-e71, 2007 | 61 | 2007 |
| Staging the axilla in breast cancer patients with 18F-FDG PET: how small are the metastases that we can detect with new generation clinical PET systems? D Bellevre, C Blanc Fournier, O Switsers, AE Dugué, C Levy, D Allouache, ... European journal of nuclear medicine and molecular imaging 41, 1103-1112, 2014 | 59 | 2014 |
Charline LasnonNuclear Medicine Physician (MD, PhD), François Baclesse Cancer CentreE-mail megerősítve itt: baclesse.unicancer.fr
